Heneghan H M, Martin S T, Winter D C
Centre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
Colorectal Dis. 2015 May;17(5):382-9. doi: 10.1111/codi.12868.
The optimal surgical approach to the management of colorectal cancer in the setting of hereditary nonpolyposis colorectal cancer (HNPCC) is contentious. While some advocate total colectomy, others perform segmental resection followed by regular endoscopic surveillance. This systematic review evaluates the evidence for segmental colectomy (SC) and total (extended) colectomy (TC) in the management of HNPCC.
Two major databases (PubMed and Cochrane) were searched using predefined terms. All original articles, published in English, comparing the oncological outcomes of SC and TC in HNPCC patients from January 1950 to July 2013 were included.
Eighty-four studies were identified. After applying exclusion criteria, six studies involving 948 patients were included (mean age 47.4 years, 51.8% male). SC was more commonly performed than TC (n = 780; 82.3%). Mean follow-up was 106.5 months. Metachronous high-risk adenomas were detected more often after SC, although the difference was not statistically significant (23.4% vs 9.6%; OR 2.258, P = 0.057). Metachronous cancers occurred more frequently after SC than after TC (23.5% vs 6.8%; OR 3.679, P < 0.005). However, there was no difference in overall survival (90.7% vs 89.8% for SC and TC, respectively; P = 0.085). Only one study reported operative mortality (0% in each group), there was no report of operative morbidity or functional outcome.
The optimal surgical approach in the management of HNPCC remains unclear. More adenomas and cancers occur after SC than after TC but there certainly is no evidence to suggest that more radical surgery leads to improved survival.
在遗传性非息肉病性结直肠癌(HNPCC)背景下,结直肠癌的最佳手术治疗方法存在争议。一些人主张行全结肠切除术,另一些人则进行节段性切除,随后进行定期内镜监测。本系统评价评估了节段性结肠切除术(SC)和全(扩大)结肠切除术(TC)在HNPCC治疗中的证据。
使用预定义术语检索两个主要数据库(PubMed和Cochrane)。纳入所有1950年1月至2013年7月发表的、比较HNPCC患者SC和TC肿瘤学结局的英文原创文章。
共识别出84项研究。应用排除标准后,纳入6项研究,涉及948例患者(平均年龄47.4岁,男性占51.8%)。SC的实施比TC更常见(n = 780;82.3%)。平均随访时间为106.5个月。SC后异时性高危腺瘤的检出率更高,尽管差异无统计学意义(23.4%对9.6%;OR 2.258,P = 0.057)。SC后异时性癌的发生频率高于TC(23.5%对6.8%;OR 3.679,P < 0.005)。然而,总生存率无差异(SC和TC分别为90.7%和89.8%;P = 0.085)。只有一项研究报告了手术死亡率(每组均为0%),没有关于手术并发症或功能结局的报告。
HNPCC治疗的最佳手术方法仍不明确。SC后发生的腺瘤和癌比TC后更多,但肯定没有证据表明更激进的手术能提高生存率。